Skip to main content

Together we are beating cancer

Donate now

Interview

Showing 12 out of 54 results
sally george

Sally George on targeted treatments, monitoring circulating tumour DNA and precision medicine for young cancer patients… Sally George on targeted treatments, monitoring circulating tumour DNA and precision medicine for young cancer patients…

by Phil Prime | Interview | 19 March 2025

19 March 2025

PPI

What can patient and public involvement achieve and how can you show you are getting the most from it when you apply for funding? What can patient and public involvement achieve and how can you show you are getting the most from it when you apply for funding?

by Phil Prime | Interview | 24 February 2025

24 February 2025

Michael Baumann
  • For Researchers

A real early detection ace

As two new partners join ACED, Professor Michael Baumann talks about the complexities and excitement of the early detection field…   As two new partners join ACED, Professor Michael Baumann talks about the complexities and excitement of the early detection field…  

by Phil Prime | Interview | 13 February 2025

13 February 2025

Lucy Brooks

Dr Lucy Brooks talks glioblastoma microenvironments and her excitement around potential new treatments Dr Lucy Brooks talks glioblastoma microenvironments and her excitement around potential new treatments

by Phil Prime | Interview | 30 October 2024

30 October 2024

Joanna Edwards

Professor Joanne Edwards tells us about using AI to generate incredible insights from biological scans and histological stains. Professor Joanne Edwards tells us about using AI to generate incredible insights from biological scans and histological stains.

by Phil Prime | Interview | 16 October 2024

16 October 2024

David Jenkinson

We chatted to David Jenkinson of LifeArc about C-Further, our new children's cancer therapeutic consortium. We chatted to David Jenkinson of LifeArc about C-Further, our new children's cancer therapeutic consortium.

by Phil Prime | Interview | 8 October 2024

8 October 2024